Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Automated Compounding Device (Oncology) Market to Expand at a Healthy CAGR during the Study Period 2018-26 in the 7MM, Foretells DelveInsight

This image opens in the lightbox

News provided by

DelveInsight Business Research, LLP

15 Jul, 2021, 17:30 GMT

Share this article

Share toX

Share this article

Share toX

The steep rise in the Automated Compounding Device (Oncology) Market can be ascribed to the emergent need to reduce medicinal errors and a growing preference of cancer patients for personalized medicines and chemotherapy. 

LAS VEGAS, July 15, 2021 /PRNewswire/ -- DelveInsight's Automated Compounding Device (Oncology) Market Insights and Forecast report provides the current and forecast Automated Compounding Device (Oncology) market, individual market shares of the devices, upcoming innovation in the devices, challenges, and drivers and comprises market trends and key competitors in the Automated Compounding Device (Oncology) market. 

Some of the key takeaways from the Automated Compounding Device (Oncology) Market report: 

  • The United States accounts for the majority of the Automated Compounding Devices (Oncology) market size in 2021 in the 7MM.
  • France accounts for the highest ACD (Oncology) market size in the EU5 countries followed by Germany, the UK, Italy, and Spain.
  • As per DelveInsight's Automated Compounding Devices (Oncology) market analysis, the majority of the end-users for ACD (Oncology) devices constitute hospitals and chemotherapy centers.
  • Key companies actively operating in the Automated Compounding Devices (Oncology) market include Comecer, Arxium, Loccioni, ICU Medical, Omnicell, Inc, Baxter Healthcare Corporation, Grifols International, S.A., Equashield, B. Braun Medical Inc., Weibond Technologies, among others.
  • Key factors expediting the growth of the Automated Compounding Devices (Oncology) market size include an increase in the adoption of chemotherapy and personalized medicine, reduced exposure to cytotoxic compounds, better efficiency, and accuracy proffered by the devices, and a comparatively reduced risk of contamination. 
  • The Automated Compounding Devices (Oncology) market size growth is expected to face backlash owing to the high installation cost of these devices and a lack of skilled resources.
  • On 6 December 2018, Arxium had launched its cGMP RIVA IV, a fully automated compounding system for hospitals and outsourcing pharmacies.
  • Fagron acquired JCB Laboratories in the year 2015 to reshape the U.S. Sterile Compounding Industry and it had announced in 2019 about opening one of the largest 503B human drug outsourcing facilities in the U.S.
  • On 23 January 2018, an array of hospitals had adopted Omnicell's IV compounding technology across North Carolina, for the purpose of enhancing safety, providing improved therapy, reduction in costs, and facilitating compliance in the IV room.

Know which MedTech player is expected to be the growth king @ Automated Compounding Device (Oncology) Market Insights and Forecast

Automated Compounding Device (Oncology): Overview 

Automated Compounding Device (Oncology) are the devices that help in aseptically transfer one or more sterile component solutions to a sterile final container for patient preparation, thus, minimizing the use of syringes for the same purpose. The devices are known for offering better accuracy of ingredient delivery along with reducing the preparation time as well as limiting the injuries on the patients.

Discover more about the device, its components, and working mechanism @ Automated Compounding Device (Oncology) Devices 

Automated Compounding Device (Oncology) Devices Market

The Automated Compounding Device (Oncology) market is witnessing a lot of shuffling in the market with several ongoing trials investigating the safety and efficacy of the devices, collaborations and deals happening in the space, and a gamut of MedTech players setting their food in the market. As per DelveInsight's ACD (Oncology) market analysis, the market is segmented by technology, product type, and end-user. The devices based on product type are further segmented into Macro, Micro, and Macro/Microdevices. The devices based on technology are divided into Gravimetric and Volumetric devices. The end-user Automated Compounding Device (Oncology) Devices market is majorly dominated by hospitals and chemotherapy centers. 

The market of the Automated Compounding Devices (Oncology) is driven due to the reduction of the cost incurred at the hospitals per dose and elimination of contamination which is required during compounding solutions. Also, the growing need required for reducing medicinal errors are factors responsible for the growth of the Automated Compounding Devices (Oncology) market size at a high CAGR during the forecast period. 

Automated Compounding Device (Oncology) Devices Portfolio

Device 

Company

Technology

APEX® Compounding System

B. Braun Medical Inc.

Gravimetric/ Volumetric

Equashield Pro

Equashield

Gravimetric

KIRO® Oncology

Grifols International, S.A

Gravimetric

 IV pharmacy compounding automation

Omnicell

Gravimetric

Diana™

Compounding Workflow System

ICU Medic

Gravimetric

RIVA IV compounding system

Arxium

Volumetric

Pharmoduct

 Comecer

Gravimetric/ Volumetric

WEINAS PD-160 series

Weibond Technology

Gravimetric

Get in touch to know which device is expected to enter the market first @ Automated Compounding Device (Oncology) Pipeline Analysis and Competitive Assessment 

Key MedTech Players in the Automated Compounding Device (Oncology) Market

  • Comecer
  • Arxium
  • Loccioni
  • ICU Medical
  • Omnicell Inc
  • Baxter Healthcare Corporation
  • Grifols International
  • S.A., Equashield
  • B. Braun Medical Inc.

Automated Compounding Device (Oncology) Devices Market Dynamics 

The Automated Compounding Device (Oncology) Devices market size growth is expected to pick up its pace attributable to factors such as rising adoption rate for accurate dosage units for chemotherapy drugs, an inclination towards personalized medicines, continuous technological advancements, less exposure to cytotoxic compounds to personnel, low errors during dosage preparations, minimal risks, and contamination rate. However, a high installation cost of the device appears to be challenging in the smooth adoption of the devices. Further, the devices are categorized under class II medical devices, which asks the sponsor to comply with the Quality Management System (QMS) that meets FDA Quality System Regulation (QSR) making their regulatory approval quite stringent. 

Know more about which MedTech player is set to emerge as the trendsetter @ Automated Compounding Device (Oncology) Market Key Companies and Pipeline Therapies

Table of Content

1

Key Insights

2

Executive Summary of Automated Compounding Devices (Oncology)

3

Automated Compounding Devices (Oncology): Background and Overview

4

Automated Compounding Device (Oncology): Regulatory Approval 

5

Automated Compounding Devices (Oncology): Reimbursement Scenario

6

Automated Compounding Devices (Oncology): Competitive Analysis of Listed Products

7

Automated Compounding Devices: Market Analysis in 7MM

8

Country-Wise Market size of Automated Compounding Devices in 7MM

9

KOL's Views

10

Automated Compounding Devices (Oncology) Market Drivers

11

Automated Compounding Devices (Oncology) Market Barriers 

12

Unmet Needs in the Automated Compounding Devices (Oncology) Market

13

PEST Analysis 

14

Conclusion and Future Perspectives

15

Appendix

16

DelveInsight Capabilities 

17

Disclaimer

18

About DelveInsight

Visit to know more about the report offerings @ Automated Compounding Device (Oncology) Market Insights and Forecast 

Scope of the Report 

Coverage: 7MM

Study Period: 2018-26

Automated Compounding Device (Oncology) Market Segmentation

  • By Technology-
    • Gravimetric compounding system 
    • Volumetric compounding system
  • By Product Type-
    • Macro automated compounding systems
    • Micro automated compounding systems 
    • Macro/micro automated compounding systems
  • By End-User
    • Hospitals
    • Chemotherapy centers

Automated Compounding Device (Oncology) Key Companies: Comecer, Arxium, Loccioni, ICU Medical, Omnicell, Inc, Baxter Healthcare Corporation, Grifols International, S.A., Equashield, B. Braun Medical Inc., Weibond Technologies, and others. 

Request for sample report for penetrated insights @ Automated Compounding Device (Oncology) Market Landscape and Future Trends

DelveInsight's Methodology 

The report provides valuable insight for clients venturing into the Automated Compounding Device (Oncology) market and acts as the source of guidance for taking strategic business decisions in the field of Automated Compounding Device (Oncology) by providing a descriptive overview of Automated Compounding Device (Oncology), various applications of Automated Compounding Device (Oncology) and their types including detailed chapters for marketed products and emerging therapies. Along with this, the report has a detailed review of the market containing historical and forecasted market size in 7MM, by understanding the trends shaping and driving the global Automated Compounding Device (Oncology).

This report has been prepared by DelveInsight's analysts after a thorough secondary and primary research into the Automated Compounding Device (Oncology) market domain. Analysis and estimations are done by taking into consideration the share of topmost companies and industry expert viewpoints of Automated Compounding Device (Oncology) of 7MM countries.

Related Reports

3d Cardiac Mapping System Market

DelveInsight's '3D Cardiac Mapping System Market Insights, Competitive Landscape and Market Forecast–2026' report offers a complete analysis of market space, pipeline therapies and key MedTech players including Biosense Webster, Inc. (Jhonson & Jhonson), Boston Scientific Corporation, Inc., Abbott, Kardium, Medtronic, Catheter Robotics, Lepu Medical, EP Solutions SA, among others. 

Advanced Wound Care Market

DelveInsight's 'Advanced Wound Care (AWC) Market Insights, Competitive Landscape and Market Forecast-2026' report offers a complete analysis of market space, pipeline therapies and key MedTech players including Smith & Nephew plc, Acelity L.P. Inc., Mölnlycke Health Care AB, Convatecgroup, Coloplast, Paul Hartmann AG, Medtronic plc., 3M Company, Integra LifeSciences Holding Corporation, Lohmann & Rauscher International GmbH & Co. KG, and others.

Adult Spinal Deformity Market

DelveInsight's 'Adult Spinal Deformity Market Insights, Competitive Landscape and Market Forecast - 2026' report offers a complete analysis of market space, pipeline therapies and key MedTech players including NuVasive, Inc., Stryker, B. Braun Melsungen AG, Zimmer Biomet, Globus Medical, Orthofix Medical Inc., Abbott, RTI Surgical, Boston Scientific Corporation, SeaSpine, among others. 

Angio Suites Market

DelveInsight's 'Angio Suites Market Insights, Competitive Landscape and Market Forecast-2026' report offers a complete analysis of market space, pipeline therapies and key MedTech players including GE Healthcare, Philips Healthcare, Canon Medical Systems Corp., Shimadzu Corp., Siemens Healthcare GmbH, Koninklijke Philips N.V., and others.

Apheresis Market

DelveInsight's 'Apheresis - Market Insights, Competitive Landscape and Market Forecast–2026' report offers a complete analysis of market space, pipeline therapies and key MedTech players including Terumo BCT, Inc., Fresenius SE & Co. KGaA, Haemonetics Corporation, Asahi Kasei Medical Co. Ltd., B. Braun Melsungen AG, Baxter International Inc., Cerus Corporation, Kaneka Corporation, Kawasumi Laboratories, Inc., Nikkiso Co., Ltd., and several others. 

Artificial Disc Market

DelveInsight's 'Artificial Disc Market Insights, Competitive Landscape and Market Forecast - 2026' report offers a complete analysis of market space, pipeline therapies and key MedTech players including Globus Medical, Zimmer Biomet, B. Braun Melsungen, Centinel Spine, LLC, Medtronic Plc, AxioMed LLC, NuVasive Inc, Orthofix Medical Inc, K2M, Inc, RTI Surgical Holdings, Inc, Synergy Disc Replacement Inc., and others. 

Related Posts

Neurovascular Thrombectomy Devices Market

Wearable Devices: Pros and Cons

Diabetic Macular Edema Therapy Market

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance. 

Manage portfolio, expand business, audit market with DelveInsight's Consulting Solutions and Services. 

Contact Us:

Shruti Thakur 
info@delveinsight.com  
+1(919)321-6187 
www.delveinsight.com

Logo: https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg 

Modal title

Also from this source

GPRC5D-directed Therapies Market is Anticipated to Gain Momentum During the Forecast Period (2025-2034) Owing to Unmet Need in Multiple Myeloma | DelveInsight

GPRC5D-directed Therapies Market is Anticipated to Gain Momentum During the Forecast Period (2025-2034) Owing to Unmet Need in Multiple Myeloma | DelveInsight

DelveInsight's GPRC5D-directed Therapies Market Size, Target Population, Competitive Landscape & Market Forecast report includes a comprehensive...

Sleep Apnea Market to Accelerate Substantially at a CAGR of 20% During the Study Period (2020-2034) | DelveInsight

Sleep Apnea Market to Accelerate Substantially at a CAGR of 20% During the Study Period (2020-2034) | DelveInsight

DelveInsight's Sleep Apnea Market Insights report includes a comprehensive understanding of current treatment practices, sleep apnea emerging drugs,...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Equipment

Medical Equipment

Medical Pharmaceuticals

Medical Pharmaceuticals

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.